WHAT SURGEONS ARE TALKING ABOUT

“What’s most exciting about AlloFlo [Uveo] really is that it’s a completely new pathway of treatment.”

“The kind of patients that can benefit from [AlloFlo Uveo] is pretty broad. I’ve done both mild and moderate, all the way to the severe spectrum—patients who’ve actually failed multiple larger surgeries.”

“These products really excite me because they’re giving me the ability to go into the uveoscleral space, which we haven’t had access to… we know it works.”

“We’ve known for a long time that the uveoscleral pathway is the most prominent pathway that gets the pressure down. If we can get to it… then we win.”

“The more tools we have in our tool chest, the greater the armamentarium we have in order to select the right tool in order to precisely help that patient.”

“It opens the door to have more options in between the Schlemm’s Canal and doing the [subconjunctival] procedure—the bleb procedures.”